Sherlock Biosciences Funding: $111M Raised, Series B (2022)
Sherlock Biosciences is based in Boston. It has raised $111M in total funding. Latest round: Series B.
Sherlock Biosciences funding overview
Sherlock Biosciences is based in Boston. Sherlock Biosciences has raised $111M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in March 2022. The round record for Sherlock Biosciences runs through 2022; nothing later has been disclosed. Investors on record include Novalis LifeSciences, Illumina Ventures, Albany Capital, Catalio Capital Management, Northpond Ventures, Good Ventures. 6 distinct backers are named across the disclosed rounds.
Sherlock Biosciences at a glance
Total raised
$111M
Latest round
Series B
Latest round date
March 2022
Headquarters
Boston
Notable investors
Novalis LifeSciences, Illumina Ventures, Albany Capital, Catalio Capital Management, Northpond Ventures, Good Ventures
Frequently asked about Sherlock Biosciences funding
How much has Sherlock Biosciences raised?
Sherlock Biosciences has raised $111M in total disclosed funding across the rounds on record.
Who has invested in Sherlock Biosciences?
Novalis LifeSciences, Illumina Ventures, Albany Capital, Catalio Capital Management, Northpond Ventures, Good Ventures are named among the investors backing Sherlock Biosciences.
What was the latest Sherlock Biosciences funding round?
The most recent disclosed round is a Series B, announced in March 2022.
Where is Sherlock Biosciences based?
Sherlock Biosciences is based in Boston.
When did Sherlock Biosciences last raise?
The last disclosed Sherlock Biosciences round closed in March 2022 at Series B.
Every Sherlock Biosciences figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Boston at a similar stage.
